Surety Medicine 
Medical Review Officer duties related to the PRP may include helping to identify any substance use disorders.  NHTSA photo. 

The role of the Medical Review Officer (MRO) related to the Personnel Reliability Program may involve helping to identify substance abuse and other disorders.                                                        
                                                                                         - National Highway Traffic Safety Administration photo

December 2017 Surety Medicine Teleconference:

Wednesday, 13 December 2017 will bring the next Surety Medicine Teleconference,
at 1 pm (1300 hrs) Eastern Time.  The topic for December is "Medical Review Officer Functions in Support of the Personnel Reliability Program.”  The presenter will be the Senior Occupational Medicine Physician for the U.S. Army Public Health Center Surety Medicine Division.  Note the December Surety Medicine Teleconference is occurring one week early due to the upcoming holiday.

To request additional information, email the Army Public Health Center Surety Medicine Division at:



13 DEC 2017
Medical Review Officer Functions in Support of the PRP
17 JAN 2018
Screening for Dementia and Cognitive Impairments:  PRP Suitability & Reliability
21 FEB 2018
Ergonomics and the Personnel Reliability Program  
21 MAR 2018
Updates in the Diagnosis and Treatment of Nerve & Vesicant Agent Exposures
18 APR 2018
Hearing Conservation and Audiometric Testing in Surety Programs 
16 MAY 2018
HIV:  CD4 Counts, Antiretroviral Drugs, and Impaired Immune Functions in PRP
27 JUN 2018
Diagnosis, Evaluation and Screening of Laboratory-Acquired Alpha Virus Infections
18 JUL 2018
Screening Diabetics for Reliability and Suitability in the PRP
15 AUG 2018
Case Studies in Personnel Reliability Program Surety Management
26 SEP 2018
Animal Worker Occupational Health Issues in the PRP


Autoinjector Shelf Life Extension Program:  UPDATED JULY 5, 2017


Many expiration date extensions for autoinjector medications expire in 2017!  Check any auto-injector medication stores you have.  Select the link below for additional information from the FDA.

The US Food and Drug Administration (FDA) is alerting health care professionals and emergency responders that specific lots of DuoDote combined nerve agent antidote auto-injectors have been approved for shelf life extensions beyond labeled expiration dates, some are now extended to 2022.  Complete FDA information related to the auto-injector shelf life extension program can be found at: .  

Information on this page also includes the latest updates (6/26/2017) on shelf life
extensions for the AtroPen (atropine), CANA (diazepam), morphine sulfate, and
pralidoxime chloride auto-injectors. 


Related programs and contacts